These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 26088121)
21. Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety. Laprevote V; Schwan R; Schwitzer T; Rolland B; Thome J Curr Pharm Des; 2015; 21(23):3298-305. PubMed ID: 26088109 [TBL] [Abstract][Full Text] [Related]
22. Plasticity of GABAB receptor in rat spinal cord detected by autoradiography. Malcangio M; Da Silva H; Bowery NG Eur J Pharmacol; 1993 Nov; 250(1):153-6. PubMed ID: 8119313 [TBL] [Abstract][Full Text] [Related]
23. Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder. Rolland B; Jaillette E; Carton L; Bence C; Deheul S; Saulnier F; Bordet R; Cottencin O J Clin Psychopharmacol; 2014 Feb; 34(1):153-6. PubMed ID: 24346755 [TBL] [Abstract][Full Text] [Related]
24. Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System. Hulse G; Kelty E; Hood S; Norman A; Basso MR; Reece AS Curr Pharm Des; 2015; 21(23):3325-42. PubMed ID: 26088116 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and Evaluation of a New Naik R; Valentine H; Dannals RF; Wong DF; Horti AG ACS Chem Neurosci; 2018 Jun; 9(6):1453-1461. PubMed ID: 29498831 [TBL] [Abstract][Full Text] [Related]
26. Editorial: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze. Rolland B; Amad A Curr Pharm Des; 2015; 21(23):3274-5. PubMed ID: 26238988 [No Abstract] [Full Text] [Related]
27. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial. Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622 [TBL] [Abstract][Full Text] [Related]
28. Role of CA1 GABA Ebrahimi-Ghiri M; Rostampour M; Jamshidi-Mehr M; Nasehi M; Zarrindast MR Brain Res; 2018 Jan; 1678():164-173. PubMed ID: 29038006 [TBL] [Abstract][Full Text] [Related]
29. GABAB receptors inhibit low-voltage activated and high-voltage activated Ca(2+) channels in sensory neurons via distinct mechanisms. Huang D; Huang S; Peers C; Du X; Zhang H; Gamper N Biochem Biophys Res Commun; 2015 Sep; 465(2):188-93. PubMed ID: 26239659 [TBL] [Abstract][Full Text] [Related]
30. Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists. Froestl W; Mickel SJ; Hall RG; von Sprecher G; Strub D; Baumann PA; Brugger F; Gentsch C; Jaekel J; Olpe HR J Med Chem; 1995 Aug; 38(17):3297-312. PubMed ID: 7650684 [TBL] [Abstract][Full Text] [Related]
31. Baclofen for the treatment of alcohol dependence. Howland RH J Psychosoc Nurs Ment Health Serv; 2012 Oct; 50(10):11-4. PubMed ID: 22998536 [TBL] [Abstract][Full Text] [Related]
32. Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex. Bonanno G; Fassio A; Schmid G; Severi P; Sala R; Raiteri M Br J Pharmacol; 1997 Jan; 120(1):60-4. PubMed ID: 9117099 [TBL] [Abstract][Full Text] [Related]
33. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety. Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397 [TBL] [Abstract][Full Text] [Related]
34. Chronic baclofen desensitizes GABA(B)-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain. Keegan BM; Beveridge TJ; Pezor JJ; Xiao R; Sexton T; Childers SR; Howlett AC Neuropharmacology; 2015 Aug; 95():492-502. PubMed ID: 25724082 [TBL] [Abstract][Full Text] [Related]